Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
367 Ergebnisse
| PL3VE2 |  | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 34,515 % | 0,308 | -0,014 | 7,333 | 15.01.2027 | 0,100 | BNP Paribas | |
| PL3VE1 | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 34,926 % | 0,283 | -0,015 | 8,029 | 18.12.2026 | 0,100 | BNP Paribas | |
| PL68K1 | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 38,849 % | 0,162 | -0,018 | 13,115 | 18.09.2026 | 0,100 | BNP Paribas | |
| PJ90BR | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 35,793 % | 0,365 | -0,014 | 5,861 | 19.03.2027 | 0,100 | BNP Paribas | |
| PK0015 | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 38,279 % | 0,490 | -0,011 | 3,612 | 17.12.2027 | 0,100 | BNP Paribas | |
| PK507D | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 38,644 % | 0,501 | -0,011 | 3,459 | 21.01.2028 | 0,100 | BNP Paribas | |
| PK512T | | Edwards Lifesciences Corp./OS/Call [100]/BNP | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 39,192 % | 0,519 | -0,011 | 3,248 | 17.03.2028 | 0,100 | BNP Paribas | |
| JZ1R5X | Edwards Lifesciences Corp./OS/Call [100]/JPM | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 32,681 % | 0,296 | -0,013 | 7,802 | 15.01.2027 | 0,100 | JP Morgan | ||
| JZ7U04 | Edwards Lifesciences Corp./OS/Call [100]/JPMD | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 33,064 % | 0,268 | -0,014 | 8,603 | 18.12.2026 | 0,100 | JP Morgan | ||
| JZ922C | Edwards Lifesciences Corp./OS/Call [100]/JPMD | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 49,909 % | 0,135 | -0,027 | 14,718 | 21.08.2026 | 0,100 | JP Morgan | ||
| JE1N6X | Edwards Lifesciences Corp./OS/Call [100]/JPMD | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 35,893 % | 0,140 | -0,015 | 14,600 | 18.09.2026 | 0,100 | JP Morgan | ||
| JE0U85 | Edwards Lifesciences Corp./OS/Call [100]/JPMD | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 35,829 % | 0,365 | -0,014 | 5,857 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE6QA2 | Edwards Lifesciences Corp./OS/Call [100]/JPMD | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 35,802 % | 0,255 | -0,016 | 8,935 | 20.11.2026 | 0,100 | JP Morgan | ||
| MJ3UXU | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 45,474 % | 0,353 | -0,021 | 5,929 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9KWT | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 44,571 % | 0,461 | -0,015 | 3,911 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5HLZ | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 53,960 % | 0,258 | -0,033 | 8,499 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034F | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 51,907 % | 0,547 | -0,014 | 2,744 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6D0S | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 44,361 % | 0,416 | -0,017 | 4,657 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRN | | Edwards Lifesciences Corp./OS/Call [100]/MS | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 60,580 % | 0,620 | -0,014 | 2,118 | 16.06.2028 | 0,100 | Morgan Stanley | |
| FD1Y57 | Edwards Lifesciences Corp./OS/Call [100]/SOC | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 39,023 % | 0,384 | -0,015 | 5,337 | 19.03.2027 | 0,100 | Société Générale | ||
| FD5GWQ | Edwards Lifesciences Corp./OS/Call [100]/SOC | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 42,572 % | 0,189 | -0,021 | 11,597 | 18.09.2026 | 0,100 | Société Générale | ||
| FD5HAE | Edwards Lifesciences Corp./OS/Call [100]/SOC | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 39,652 % | 0,319 | -0,018 | 6,922 | 18.12.2026 | 0,100 | Société Générale | ||
| FD5HAH | Edwards Lifesciences Corp./OS/Call [100]/SOC | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 38,849 % | 0,338 | -0,016 | 6,402 | 15.01.2027 | 0,100 | Société Générale | ||
| VH622D | | Edwards Lifesciences Corp./OS/Call [100]/VONT | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 36,167 % | 0,320 | -0,015 | 6,946 | 15.01.2027 | 0,100 | Vontobel | |
| VJ3CFK | | Edwards Lifesciences Corp./OS/Call [100]/VONT | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 36,833 % | 0,297 | -0,016 | 7,561 | 18.12.2026 | 0,100 | Vontobel | |
| VY46PX | | Edwards Lifesciences Corp./OS/Call [100]/VONT | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 51,259 % | 0,142 | -0,028 | 14,191 | 21.08.2026 | 0,100 | Vontobel | |
| VY5KJP | | Edwards Lifesciences Corp./OS/Call [100]/VONT | - | - | 100,000 | call | Edwards Lifesciences Corp. | - | 40,966 % | 0,180 | -0,020 | 12,069 | 18.09.2026 | 0,100 | Vontobel | |
| MM14KK | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 44,507 % | 0,438 | -0,015 | 3,996 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM14KN | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 46,040 % | 0,326 | -0,020 | 6,031 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM7M63 | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 56,552 % | 0,234 | -0,032 | 8,450 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034G | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 51,569 % | 0,531 | -0,014 | 2,798 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6D0T | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 44,744 % | 0,391 | -0,017 | 4,730 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRP | | Edwards Lifesciences Corp./OS/Call [102,5]/MS | - | - | 102,500 | call | Edwards Lifesciences Corp. | - | 61,009 % | 0,609 | -0,014 | 2,127 | 16.06.2028 | 0,100 | Morgan Stanley | |
| JE6G2E | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 35,638 % | 0,185 | -0,013 | 9,751 | 20.11.2026 | 0,100 | JP Morgan | ||
| JE67EP | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 33,347 % | 0,201 | -0,012 | 9,262 | 18.12.2026 | 0,100 | JP Morgan | ||
| JE8T8L | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 35,692 % | 0,305 | -0,013 | 6,256 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE9K84 | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 32,298 % | 0,229 | -0,011 | 8,511 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY09VU | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 37,572 % | 0,089 | -0,011 | 15,230 | 18.09.2026 | 0,100 | JP Morgan | ||
| JY3VKS | Edwards Lifesciences Corp./OS/Call [105]/JPMD | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 45,383 % | 0,055 | -0,011 | 19,098 | 21.08.2026 | 0,100 | JP Morgan | ||
| MJ5TDN | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 47,044 % | 0,304 | -0,020 | 6,064 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9KWU | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 45,223 % | 0,420 | -0,015 | 4,021 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5HM0 | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 59,271 % | 0,219 | -0,032 | 8,180 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034H | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 51,715 % | 0,515 | -0,014 | 2,830 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6D0U | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 45,301 % | 0,370 | -0,017 | 4,789 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRQ | | Edwards Lifesciences Corp./OS/Call [105]/MS | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 60,242 % | 0,596 | -0,014 | 2,167 | 16.06.2028 | 0,100 | Morgan Stanley | |
| FD5GWR | Edwards Lifesciences Corp./OS/Call [105]/SOC | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 44,397 % | 0,132 | -0,017 | 12,134 | 18.09.2026 | 0,100 | Société Générale | ||
| FD5HAJ | Edwards Lifesciences Corp./OS/Call [105]/SOC | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 39,607 % | 0,281 | -0,015 | 6,692 | 15.01.2027 | 0,100 | Société Générale | ||
| FD5HAF | Edwards Lifesciences Corp./OS/Call [105]/SOC | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 40,401 % | 0,257 | -0,016 | 7,288 | 18.12.2026 | 0,100 | Société Générale | ||
| VY5VL6 | | Edwards Lifesciences Corp./OS/Call [105]/VONT | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 43,375 % | 0,126 | -0,016 | 12,526 | 18.09.2026 | 0,100 | Vontobel | |
| VY50LN | | Edwards Lifesciences Corp./OS/Call [105]/VONT | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 52,245 % | 0,087 | -0,019 | 15,398 | 21.08.2026 | 0,100 | Vontobel |